NCT02540876
- Conditions
- Metastatic Malignant Neoplasm, Neoplasm Metastasis, Neoplasms, +5 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Clinical trial condition
Solid Neoplasm
Explore clinical trials studying Solid Neoplasm. Study availability and eligibility vary by location and protocol.
25 public trials
3 recruiting studies
Solid Neoplasm trial results
Completed
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854
- Conditions
- Agranulocytosis, Cytopenia, Fatigue, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
NCT00892736
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT00085553
- Conditions
- Solid Neoplasm
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01749384
- Conditions
- Solid Neoplasm
- Locations
-
- Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
NCT01538095
- Conditions
- Central Nervous System Neoplasm, Central Nervous System Neoplasms, Neoplasms, +4 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
NCT01017640
- Conditions
- Solid Neoplasm
- Locations
-
- Georgetown Cancer Treatment Center Georgetown, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, Not Recruiting
Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
NCT00740805
- Conditions
- Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Neoplasm
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Active, Not Recruiting
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
NCT02142803
- Conditions
- Adnexal Diseases, Adult Glioblastoma, Astrocytoma, +47 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States